Skip to Content
UW Health SMPH
David F. Jarrard, MD close

David F. Jarrard, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Jarrard is board certified by the American Board of Urology and has completed a fellowship in Urologic Oncology. He specializes in all aspects of urologic oncology with an emphasis on prostate cancer diagnosis and treatment. Dr. Jarrard is also involved with surgical treatments for prostate cancer, such as the robotic prostatectomy.

Specialties

Urology

UW Health Clinics

UW Carbone Cancer Center
(608) 263-4757 | (800) 323-8942 | Map
UW Hospital and Clinics
(608) 263-4757 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

Languages Spoken

English
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

UW School of Medicine and Public Health

Department of Urology

Professional Certifications and Education

Board Certification Urology
Fellowship

Urologic Oncology, Johns Hopkins Hospital, Baltimore, MD
Residency University of Chicago Medical Center, Chicago, IL, Chicago, IL
Internship University of Chicago Medical Center, Chicago, IL, Chicago, IL
Medical School University of Virginia, Charlottesville, VA, 1989

Awards/Honors

Madison Magazine Top Docs 2012

Best Doctors® in America 2011

Procedures

Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Research

Dr. Jarrard has a joint appointment with the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, and his clinical research emphasizes developing new therapies for genitourinary cancers. He has an active basic science laboratory and is funded through the National Institutes of Health to examine genetic and epigenetic alterations in prostate cancer.

PubMed Articles
Truong M Yang B Livermore A Wagner J Weeratunga P Huang W Dhir R Nelson J Lin DW Jarrard DF . Using the epigenetic field defect to detect prostate cancer in biopsy negative patients. J Urol. 2013 Jun;189(6):2335-41
[PubMed ID: 23159584]
Yang B Bhusari S Kueck J Weeratunga P Wagner J Leverson G Huang W Jarrard DF . Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer. Neoplasia. 2013 Apr;15(4):399-408
[PubMed ID: 23555185]
Slezak J Truong M Huang W Jarrard D . HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy. BMC Cancer. 2013 Mar 23;13:148
[PubMed ID: 23522301]
Babaian K Truong M Cetnar J Cross DS Shi F Ritter MA Jarrard DF . Analysis of urological procedures in men who died from prostate cancer using a population-based approach. BJU Int. 2013 Mar;111(3 Pt B):E65-70
[PubMed ID: 23130676]
Ewald JA Desotelle JA Church DR Yang B Huang W Laurila TA Jarrard DF . Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo. Prostate. 2013 Mar;73(4):337-45
[PubMed ID: 22911222]
Truong M Yang B Wagner J Desotelle J Jarrard DF . Analysis of promoter non-CG methylation in prostate cancer. Epigenomics. 2013 Feb;5(1):65-71
[PubMed ID: 23414321]
Truong M Yang B Jarrard DF . Toward the detection of prostate cancer in urine: a critical analysis. J Urol. 2013 Feb;189(2):422-9
[PubMed ID: 23017522]
Gee J Bailey H Kim K Kolesar J Havighurst T Tutsch KD See W Cohen MB Street N Levan L Jarrard D Wilding G . Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin. Prostate. 2013 Jan 17;
[PubMed ID: 23335089]
Ewald JA Jarrard DF . Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. Transl Oncol. 2012 Aug;5(4):278-87
[PubMed ID: 22937180]
Bhusari S Yang B Kueck J Huang W Jarrard DF . Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer. Prostate. 2011 Nov;71(15):1621-30
[PubMed ID: 21432864]
King AC Livermore A Laurila TA Huang W Jarrard DF . Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer. Urol Oncol. 2011 Aug 2;
[PubMed ID: 21816639]
Kruser TJ Jarrard DF Graf AK Hedican SP Paolone DR Wegenke JD Liu G Geye HM Ritter MA . Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence. Cancer. 2011 Jun 15;117(12):2629-36
[PubMed ID: 21656740]
Patel SR Kaplon DM Jarrard D . A technique for the management of a large median lobe in robot-assisted laparoscopic radical prostatectomy. J Endourol. 2010 Dec;24(12):1899-901
[PubMed ID: 20858064]
Ewald JA Desotelle JA Wilding G Jarrard DF . Therapy-induced senescence in cancer. J Natl Cancer Inst. 2010 Oct 20;102(20):1536-46
[PubMed ID: 20858887]
Bhusari SS Dobosy JR Fu V Almassi N Oberley T Jarrard DF . Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate. Epigenetics. 2010 Jul 1;5(5):402-9
[PubMed ID: 20458166]
Iskandar BJ Rizk E Meier B Hariharan N Bottiglieri T Finnell RH Jarrard DF Banerjee RV Skene JH Nelson A Patel N Gherasim C Simon K Cook TD Hogan KJ . Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. J Clin Invest. 2010 May;120(5):1603-16
[PubMed ID: 20424322]
Quann P Jarrard DF Huang W . Current prostate biopsy protocols cannot reliably identify patients for focal therapy: correlation of low-risk prostate cancer on biopsy with radical prostatectomy findings. Int J Clin Exp Pathol. 2010 Mar 30;3(4):401-7
[PubMed ID: 20490330]
Laurila TA Huang W Jarrard DF . Robotic-assisted laparoscopic and radical retropubic prostatectomy generate similar positive margin rates in low and intermediate risk patients. Urol Oncol. 2009 Sep-Oct;27(5):529-33
[PubMed ID: 18640061]
Ewald JA Peters N Desotelle JA Hoffmann FM Jarrard DF . A high-throughput method to identify novel senescence-inducing compounds. J Biomol Screen. 2009 Aug;14(7):853-8
[PubMed ID: 19641224]
Gee JR Waterman BJ Jarrard DF Hedican SP Bruskewitz RC Nakada SY . Flexible and rigid cystoscopy in women. JSLS. 2009 Apr-Jun;13(2):135-8
[PubMed ID: 19660204]
Gee JR Jarrard DF Bruskewitz RC Moon TD Hedican SP Leverson GE Nakada SY Messing EM . Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin. BJU Int. 2009 Mar;103(6):736-9
[PubMed ID: 19007364]